Psychedelics Decriminalization Trends in 2025: A Surge in Reform Amid Growing Evidence
Read more
Detailed Security Regulations for Cannabis and Psilocybin Facilities in Colorado and Oregon (As of December 2025)
In the evolving landscape of cannabis and psilocybin regulations, security remains a cornerstone to prevent theft, diversion, and unauthorized access. These requirements are mandated by state agencies like Colorado's Marijuana Enforcement Division (MED) and Department of Regulatory Agencies (DORA), and Oregon's Oregon Liquor and Cannabis Commission
Trump's Historic Cannabis Rescheduling: What Schedule III Actually Means for the Industry
The biggest federal cannabis policy shift in 55 years just happened. Here's what it means—and what it doesn't. On December 18, 2025, President Donald Trump signed an executive order directing the Attorney General to complete the process of rescheduling marijuana from Schedule I to Schedule
Pioneering States: Colorado and Oregon's Cannabis and Psilocybin Reforms in Late 2025
In late 2025, Colorado and Oregon stand out as trailblazers in U.S. substance policy reform, each balancing thriving cannabis industries with innovative therapeutic psilocybin programs. With the recent federal rescheduling of cannabis to Schedule III via President Trump's December 18 executive order, these states are poised for
Ketamine Regulations and Trends in Late 2025: A Growing Option for Mental Health Treatment
Psychedelics Decriminalization Trends in 2025: A Surge in Reform Amid Growing EvidenceProtecting Cannabis Businesses from Breaches & Audit FailuresCanna SecureCannaSecure As of December 2025, ketamine stands out as the most accessible legal psychedelic for therapeutic use in the United States. Unlike emerging psychedelics like psilocybin (limited to supervised programs in